Skip to main content

Serina Therapeutics, Inc.

SER
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001708599

In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Serina Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of SER: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders35213−20
SharesConverted for a 1-for-35 split141.9K2.79K109.9K−29.2K (−21.0%)
Value$1.91M$37.5K$1.48M−$395.3K (−21.1%)

2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (1)

Institutions that held Serina Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to SER in Q1 2024
InstitutionSharesValue% of portfolio
Citigroup Inc656$8.83K0.00%

Sold out (21)

Institutions that held Serina Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Not filed for Q1 2024 yet (2)

Institutions that held Serina Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SER in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Strategic Wealth Designers97,375$37.5K
Strategic Investment Solutions, Inc.150$58